139 related articles for article (PubMed ID: 27466523)
1. Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report.
Demeulenaere M; Duerinck J; DU Four S; Fostier K; Michotte A; Neyns B
Anticancer Res; 2016 Aug; 36(8):4145-9. PubMed ID: 27466523
[TBL] [Abstract][Full Text] [Related]
2. 1p/19q chromosome deletions in metastatic oligodendroglioma.
Merrell R; Nabors LB; Perry A; Palmer CA
J Neurooncol; 2006 Nov; 80(2):203-7. PubMed ID: 16710746
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic oligodendroglioma metastasizing to the bone marrow: a unique case report and literature review.
Singh VK; Singh S; Bhupalam L
Int J Neurosci; 2019 Jul; 129(7):722-728. PubMed ID: 30526175
[TBL] [Abstract][Full Text] [Related]
4. Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review.
Li G; Zhang Z; Zhang J; Jin T; Liang H; Gong L; Cui G; Yang H; He S; Zhang Y; Gao G
Diagn Pathol; 2014 Jan; 9():17. PubMed ID: 24447608
[TBL] [Abstract][Full Text] [Related]
5. Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report.
Burgy M; Chenard MP; Noël G; Bourahla K; Schott R
J Med Case Rep; 2019 Jun; 13(1):202. PubMed ID: 31248444
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow metastasis in anaplastic oligodendroglioma.
Sharma A; Agarwal A; Sharma MC; Anand M; Agarwal S; Raina V
Int J Clin Pract; 2003 May; 57(4):351-2. PubMed ID: 12800473
[TBL] [Abstract][Full Text] [Related]
7. Metastatic oligodendroglioma: a case report and incidence in The Netherlands.
Krijnen JL; Fleischeur RE; van Berkel M; Westenend PJ
Clin Neuropathol; 2010; 29(3):141-6. PubMed ID: 20423687
[TBL] [Abstract][Full Text] [Related]
8. Alpha-internexin and altered CIC expression as a supportive diagnostic marker for oligodendroglial tumors with the 1p/19q co-deletion.
Nagaishi M; Suzuki A; Nobusawa S; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2014 Oct; 31(4):257-64. PubMed ID: 24197863
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy.
Hata N; Shono T; Mizoguchi M; Matsumoto K; Guan Y; Nagata S; Hayashi K; Iwaki T; Sasaki T
Neurol Res; 2007 Oct; 29(7):723-6. PubMed ID: 17553214
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow metastases from anaplastic oligodendroglioma presenting with pancytopenia and hypogammaglobulinemia: a case report.
Cordiano V; Miserocchi F; Storti M
Tumori; 2011; 97(6):808-11. PubMed ID: 22322851
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Bone Marrow Metastasis of Oligodendroglioma with IDH Mutation and 1p/19q Codeletion].
Kiko K; Suyama K; Yamamoto K; Mochida H; Oya S; Karasawa H; Watanabe S; Suzuki Y
No Shinkei Geka; 2018 Aug; 46(8):699-706. PubMed ID: 30135292
[TBL] [Abstract][Full Text] [Related]
12. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
13. Rare occurrence of IDH2 mutation in adolescent oligodendroglioma with 1p/19q co-deletion: a case report.
Rao S; Sivakoti S; Arivazhagan A; Santosh V
Childs Nerv Syst; 2020 Dec; 36(12):3109-3113. PubMed ID: 32296936
[TBL] [Abstract][Full Text] [Related]
14. 1p19q co-deleted oligodendroglioma metastatic to bone.
Greene J; Cadoo K; Ti J; O'Donnell N; Allcutt D; Farrell M; Grogan L
Clin Neuropathol; 2013; 32(2):139-41. PubMed ID: 23073167
[No Abstract] [Full Text] [Related]
15. Anaplastic oligodendroglioma arising from the brain stem and featuring 1p/19q co-deletion.
Hewer E; Beck J; Vassella E; Vajtai I
Neuropathology; 2014 Feb; 34(1):32-8. PubMed ID: 23711170
[TBL] [Abstract][Full Text] [Related]
16. Leukemia-like onset of bone marrow metastasis from anaplastic oligodendroglioma after 17 years of dormancy: an autopsy case report.
Tanaka Y; Nobusawa S; Ikota H; Yokoo H; Hirato J; Ito H; Saito T; Ogura H; Nakazato Y
Brain Tumor Pathol; 2014 Apr; 31(2):131-6. PubMed ID: 23900511
[TBL] [Abstract][Full Text] [Related]
17. Co-deletion of 1p/19q as Prognostic and Predictive Biomarker for Patients in West Bohemia with Anaplastic Oligodendroglioma.
Polivka J; Polivka J; Repik T; Rohan V; Hes O; Topolcan O
Anticancer Res; 2016 Jan; 36(1):471-6. PubMed ID: 26722084
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic study of a metastatic oligodendroglioma.
Giordana MT; Ghimenti C; Leonardo E; Balteri I; Iudicello M; Duò D
J Neurooncol; 2004 Feb; 66(3):265-71. PubMed ID: 15015656
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
Singh VY; Chacko G; Chacko AG; Rajshekhar V
Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451
[TBL] [Abstract][Full Text] [Related]
20. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
